Celltrion, Foreign Investors Net Sell 21,729 Shares... Stock Price Down 0.9%
As of 2:33 PM on the 15th, Celltrion is trading at 335,000 KRW, up 0.9% from the previous day. This is a 9.7% decrease compared to February 1. Celltrion is known as a protein and biopharmaceutical manufacturing company.
Today, foreigners have net sold 21,729 shares of Celltrion, and institutions have net sold 18,000 shares, according to provisional data. Over the past five days, individual investors have net bought 257,826 shares, while foreigners and institutions have net bought 127,547 shares and net sold 391,700 shares, respectively.
On February 8, Celltrion was a market topic with the headline "Celltrion surges following MFDS approval of COVID-19 antibody treatment."
Hot Picks Today
!["It Has Now Crossed Borders": No Vaccine or Treatment as Bundibugyo Ebola Variant Spreads [Reading Science]](https://cwcontent.asiae.co.kr/asiaresize/93/2026052019230771274_1779272587.jpg)
"It Has Now Crossed Borders": No Vaccine or Treatment as Bundibugyo Ebola Variant Spreads [Reading Science]
- Samsung Electronics Labor-Management Reach Agreement, General Strike Postponed... "Deficit-Business Unit Allocation Deferred for One Year"
- "Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "From a 70 Million Won Loss to a 350 Million Won Profit with Samsung and SK hynix"... 'Stock Jackpot' Grandfather Gains Attention
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
※ Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and financial AI specialist Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
